James Simons Pmv Pharmaceuticals, Inc

As of June 15, 2021


What is James Simons's Net Worth?

The current estimated net worth of Pmv Pharmaceuticals, Inc's James Simons is estimated to be about $8.36M . James Simons owns about 127,099 units of Pmv Pharmaceuticals, Inc common stock. In the last year at Pmv Pharmaceuticals, Inc, James Simons has sold an estimated value of $6.36M worth.

What is James Simons's Past Insider Trading?

James Simons's largest sale order was 66,396 units , worth over $2.26M on June 15, 2021. In total, James Simons has made about 4 transactions over a year of their time at Pmv Pharmaceuticals, Inc. James Simons usually trades in June, with the busiest year in 2021.

Euclidean Capital LLC, Greenland A LLC, Greenland FP LLC, Greenland NFP B Ltd, Greenland NFP LLC, Symmetry Group Ltd, Marilyn Simons, Ashvin Chhabra, JAMES SIMONS

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is James Simons's' Mailing Address?

  • Mailing address is Renaissance Technologies Llc 800 Third Ave New York NY 10022 NY

What are Pmv Pharmaceuticals, Inc's Past Insider Trades?

Pmv Pharmaceuticals, Inc's most recent insider trade came on May 31, 2022 by Orbimed Advisors Llc, Orbimed Capital GP V Llc and Orbimed Genesis GP Llc who sold 26,253 units worth $418.21K . In the last 2 years, insiders at Pmv Pharmaceuticals, Inc have sold an estimated value of $59.09M and bought an estimated value of $71.62M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Thilo Schroeder, Director,  David H. Mack, President and CEO,  and Winston Kung, COO .

PMV Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1